Vimarsana
Biggest News Aggregation in the World

Single Dose Vials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Single Dose Vials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Single Dose Vials Today - Breaking & Trending Today

Caplin Steriles Ltd receives final approval from USFDA for ANDA Cisatracurium Besylate Injection USP - Vimarsana News

Caplin Steriles Ltd receives final approval from USFDA for ANDA Cisatracurium Besylate Injection USP

Caplin Steriles Ltd, a Subsidiary company of Caplin Point Laboratories Ltd, has been granted final approval from the United States Food and Drug Administration for its ANDA Cisatracurium Besylate Injection USP.

Eugia Pharma receives USFDA Approval for Carboprost Tromethamine Injection USP 250 mcg/mL - Vimarsana News

Eugia Pharma receives USFDA Approval for Carboprost Tromethamine Injection USP 250 mcg/mL

Aurobindo Pharma Ltd's wholly owned subsidiary company, Eugia Pharma Specialties Ltd, has received a final approval from the USFDA to manufacture and market Carboprost Tromethamine Injection USP 250 mcg/mL, Single-Dose Vials.

Lupin receives approval from US FDA for Glycopyrrolate Injection, USP - Vimarsana News

Lupin receives approval from US FDA for Glycopyrrolate Injection, USP

Lupin Ltd has received approval from the U.S. FDA for its ANDA for Glycopyrrolate Injection USP, a generic equivalent of Robinul® Injection, 0.2 mg/mL of Hikma Pharmaceuticals USA Inc. This is the first approval from its Nagpur injectable facility.

Lupin receives approval from USFDA for Glycopyrrolate Injection USP - Vimarsana News

Lupin receives approval from USFDA for Glycopyrrolate Injection USP

Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S.FDA) for its abbreviated new drug application for Glycopyrrolate Injection USP, via an exchange filing.

The Latin America Blow Fill Seal Technology market to Grow at a CAGR of 6.5 % Reaching Over $478.9 million by 2028. - Vimarsana News

The Latin America Blow Fill Seal Technology market to Grow at a CAGR of 6.5 % Reaching Over $478.9 million by 2028.

Latin America Blow Fill Seal Technology Industry Trends, Demand, Growth, Value & Analysis Report by Zion Market Research